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論文の内容の要旨 
Abstract of thesis 
 
（目的 Purpose） 
The small G protein ADP-ribosylation factor 6 (Arf6) plays pivotal roles in a wide variety of 
cellular events such as endocytosis, exocytosis, and actin cytoskeleton reorganization. However, the 
physiological functions of Arf6 at the whole animal level have not been thoroughly understood. The 
purpose of this study is to clarify physiological functions of Arf6 in lymphatic endothelium in mice.  
 
（対象と方法 Materials and Methods） 
The applicant generated and analyzed lymphatic endothelial cell (LEC)-specific Arf6 conditional 
knockout (LEC-Arf6 cKO) mice. Whole-mount immunofluorescence staining of embryonic dorsal 
skin was performed to visualize the lymphatic vessel network on the skin of embryos. 
Transplantation of B16 melanoma cells was further conducted in adult LEC-Arf6 cKO mice to study 
tumor lymphangiogenesis. In addition, human LECs (hLECs) were utilized to investigate the 
cellular mechanism of Arf6 in LECs by transfecting Arf6 siRNA, followed by in vitro capillary tube 
formation assay, cell proliferation and migration assays, and β1 integrin internalization assay. 
Western blotting was used to determine the expression level of Arf6 and β1 integrin in Arf6-
knocked-down LECs. The level of activated β1 integrin and focal adhesion formation in Arf6-
knocked-down LECs were analyzed by immunofluorescence staining and confocal microscopy. 
 
（結果 Results） 
The applicant showed that Arf6 regulated developmental and tumor lymphangiogenesis in mice. 
 LEC-Arf6 cKO mouse embryos exhibited severe skin edema and impairment in the formation of 
lymphatic vessel network at the mid-gestation stage. Furthermore, the applicant found that 
knockdown of Arf6 in hLECs inhibited in vitro capillary tube formation and directed cell migration 
induced by vascular endothelial growth factor-C (VEGF-C), and Arf6 mediated VEGF-C induced cell 
migration through the internalization of β1 integrin. Finally, the applicant found that LEC-Arf6 
cKO mice transplanted with B16 melanoma cells attenuated tumor lymphangiogenesis and 
progression.  
 
（考察 Discussion） 
1) The molecular mechanism for VEGF-dependent Arf6-mediated β1 integrin recycling in LECs 
still remains unclear. However, activation of Arf6 through Arf6 GEFs in LECs in response to VEGF-
C stimulation could be essential for integrin recycling.  
2) Two lipid-metabolizing enzymes, phosphatidylinositol 4-phosphate 5-kinase and phospholipase 
D1 may be the cellular signaling downstream of the activated Arf6 that couples to β1 integrin 
endocytosis in VEGF-C-stimulated LECs.  
3) Appropriate cycling of Arf6 between activation and inactivation that are precisely regulated by 
Arf6-specifci GEFs and GAPs, respectively, may be essential for the development of dermal 
lymphatic vascular network.  
4) Ablation of Arf6 from both venous and non-venous mesenchymal cells in Arf6-deficinet embryos 
may induce lymphedema at earlier stage than in LEC-Arf6-cKO.  
 
（結論 Conclusion） 
These results provide evidence that Arf6 in LECs plays a crucial role in physiological and 
pathological lymphangiogenesis.    
 
 
審査の結果の要旨 
 Abstract of assessment result 
 
（批評 General Comments） 
Mr. Lin clearly demonstrated by using LEC-specific Arf6 knockout mice that Arf6 was essential 
for dermal lymph vessel development in vivo. Mechanistically, the applicant proposed that Arf6 was 
essential for VEGF-C-induced tube formation and directed migration of LECs by regulating 
internalization of β1 integrin from the plasma membrane and modulating the amount of active β1 
integrin. These findings are novel and provide new insight into the mechanism of lymphangiogenesis 
in vivo. Furthermore, the applicant showed that deletion of Arf6 in LECs suppressed tumor growth 
and tumor angiogenesis, suggesting that inhibition of Arf6 could serve as a novel strategy to treat 
subsets of tumors in vivo.  
 
（最終試験の結果 Assessment） 
The final examination committee conducted a meeting as a final examination on October 25, 
2017. The applicant provided an overview of dissertation, addressed questions and comments raised 
during Q&A session. All of the committee members reached a final decision that the applicant has 
passed the final examination. 
 
（結論 Conclusion） 
Therefore, the final examination committee approved that the applicant is qualified to be awarded 
Doctor of Philosophy in Medical Sciences.  
